Abstract:OBJECTIVES:Recent experimental evidence has indicated that interstitial tumor-associated macrophages (TAMs), tumor-derived macrophage colony-stimulating factor (also known as CSF-1), and interleukin-6 (IL-6) interact in the pathogenesis of malignant epithelial tumors, including lung cancer. The present study aimed to explore their relationship and prognostic significance in surgically resected non-small cell lung cancer (NSCLC). METHODS:Tissue microarray and immunohistochemistry were used to detect the expression of CSF-1, IL-6, and CD68-positive TAMs in 417 patients with NSCLC undergoing complete pulmonary resection from 2003 to 2008. Their correlations and clinicopathologic data were analyzed using chi-square testing. Their prognostic values were evaluated by univariate Kaplan-Meier survival analysis and multivariate Cox proportional hazard model analysis. RESULTS:The expression of CSF-1 and IL-6 in NSCLC correlated positively with the infiltration degree of TAMs in the tumor stroma (r=0.184 and r=0.196, respectively; P<.001). The expression of both CSF-1 and IL-6 was statistically significant for survival (P<.001). Nevertheless, no such relationship was observed for CD68 in the tumor stroma (P>.05). When CSF-1 and/or IL-6 and CD68 were taken into consideration together, the result became statistically significant. Multivariate analysis showed that co-expression of CD68, CSF-1, and IL-6 remained the most significant and independent prognostic factor for survival (P<.05) but not the combinations of CSF-1 and IL-6, CD68 and CSF-1, or CD68 and IL-6 (P>.05). The 5-year survival rate in the CD68-negative and CSF-1- and IL-6-positive group was better than the rate in the CD68, CSF-1-, and IL-6-positive group (P<.05). CONCLUSIONS:The combination of CD68 plus TAMs, CSF-1, and IL-6 is very likely to be a valuable independent predictor of survival in patients with NSCLC. Perhaps co-expression of CSF-1 and IL-6 induces interstitial TAMs to shift toward the tumor-promoting phenotype.

Expression of Monocyte Chemoattractant Protein-1 and CC Chemokine Receptor 2 in Non-Small Cell Lung Cancer and Its Significance

ERCC1, RRM1 and BRCA1 Mrna Expression Levels and Clinical Outcome of Advanced Non-Small Cell Lung Cancer.

Expression of ERCC1 in the Patients with Non-Small-cell Lung Cancer

Expression of the cyclooxygenase-2 gene and its clinical significance in non-small cell lung cancer

CCL2/CCR2 Axis is Associated with Postoperative Survival and Recurrence of Patients with Non-Metastatic Clear-Cell Renal Cell Carcinoma.

[Clinical Significance of Multidrug Resistance-Associated Protein(mrp) Gene Expression in Non-Small Cell Lung Cancer].

An inter-correlation among chemokine (C-X-C motif) ligand (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and survival profiles in non-small cell lung cancer patients

Positive Expression of P53, C-Erbb2 and MRP Proteins is Correlated with Survival Rates of NSCLC Patients.

Expression of CXCR4 and Non-Small Cell Lung Cancer Prognosis: a Meta-Analysis.

Expression of CXCL8 and its relationship with prognosis in patients with non-small cell lung cancer

Expression of P53,mrp and C-Erbb2 in Non-Small Cell Lung Cancer and Its Clinicopathological Significance

Association Between CXCL16/CXCR6 Expression and the Clinicopathological Features of Patients with Non-Small Cell Lung Cancer.

High Expression of C-C Chemokine Receptor 2 Associates with Poor Overall Survival in Gastric Cancer Patients after Surgical Resection

Microenvironment and Immunology CXCR 2 Expression inTumorCells Is aPoorPrognosticFactor and Promotes Invasion and Metastasis in Lung Adenocarcinoma

High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma.

Upregulation of the Chemokine Receptor CCR7 Expression by HIF-1αand HIF-2α in Non-Small Cell Lung Cancer

CXC Chemokine Receptor 2 is Associated with Postoperative Recurrence and Survival of Patients with Non-Metastatic Clear-Cell Renal Cell Carcinoma.

High CXC chemokine receptor 1 level represents an independent negative prognosticator in non-metastatic clear-cell renal cell carcinoma patients.

Expression and clinical significance of PD-L1 and c-Myc in non-small cell lung cancer

High expression of CXCR2 is associated with tumorigenesis, progression, and prognosis of laryngeal squamous cell carcinoma

Interstitial Tumor-Associated Macrophages Combined with Tumor-Derived Colony-Stimulating Factor-1 and Interleukin-6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer.